Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma

References

• Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, . European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2006;37:439–49.
   PubMed Web of Science ®Google Scholar
• Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K, . Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant. 2009;43:275–91.
   PubMed Web of Science ®Google Scholar
• Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, . Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 2000;96:2240–5.
   PubMed Web of Science ®Google Scholar
• Naumov GN, Folkman J, Straume O. Tumor dormancy due to failure of angiogenesis: role of the microenvironment. Clin Exp Met. 2009;26:51–60.
   PubMed Web of Science ®Google Scholar
• Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res Treat. 1996; 41:177–85.
   PubMed Web of Science ®Google Scholar
• Akkök CA, Liseth K, Nesthus I, Løkeland T, Tefre K, Bruserud O, . Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation. Transfusion. 2008;48:877–83.
   PubMed Web of Science ®Google Scholar
• Liseth K, Ersvær E, Abrahamsen JF, Nesthus I, Ryningen A, Bruserud Ø. Long-term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells. Transfusion. 2009;49:1709–19.
   PubMed Web of Science ®Google Scholar
• Bechard D, Meignin V, Scherpereel A, Severine Oudin S, Kervoaze G, Bertheau P, . Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies. J Vasc Res. 2000;37:417–25.
   PubMed Web of Science ®Google Scholar
• Ryningen A, Stapnes C, Paulsen K, Lassalle P, Gjertsen BT, Bruserud O. In vivo biological effects of ATRA in the treatment of AML. Expert Opin Investig Drugs. 2008;17: 1623–33.
   PubMed Web of Science ®Google Scholar
• Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, . International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia. 2006;20:1467–73
   PubMed Web of Science ®Google Scholar
• Caine GJ, Lip GY, Blann AD. Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis. Ann Med. 2004;36:273–7.
   PubMed Web of Science ®Google Scholar
• Seidel C, Børset M, Turesson I, Abildgaard N, Sundan A, Waage A for the Nordic Myeloma Study Group. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. Blood. 1998;91:806–12.
   PubMed Web of Science ®Google Scholar
• Seidel C, Lenhoff S, Brabrand S, Anderson G, Standal T, Lanng-Nielsen J, . Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy. Br J Haematol. 2002;119:672–6.
   PubMedGoogle Scholar
• Hov H, Holt RU, Rø TB, Fagerli UM, Hjorth-Hansen H, Baykov V, . A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells. Clin Cancer Res. 2004;10:6686–94.
   PubMedGoogle Scholar
• Hov H, Tian E, Holien T, Holt RU, Våtsveen TK, Fagerli UM, . c-Met signaling promotes IL-6-induced myeloma cell proliferation. Eur J Haematol. 2009;82:277–87.
   PubMedGoogle Scholar
• Pour L, Svachova H, Adam Z, Almasi M, Buresova L, Buchler T, . Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response. Ann Hematol. 2010;89:385–9.
   PubMed Web of Science ®Google Scholar
• Fujii K, Ishimaru F, Kozuka T, Matsuo K, Nakase K, Kataoka I, . Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br J Haematol. 2004;124:190–4.
   Google Scholar
• Jalili A, Shirvaikar N, Marquez-Curtis LA, Turner AR, Janowska-Wieczorek A. The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells. Stem Cells Dev. 2010;19:1143–51.
   PubMed Web of Science ®Google Scholar
• Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, . Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 2005;19:2005–7.
   PubMed Web of Science ®Google Scholar
• Glenjen N, Mosevoll KA, Bruserud Ø. Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia. Int J Cancer. 2002;101:86–94.
   PubMed Web of Science ®Google Scholar
• Foss B, Abrahamsen JF, Bruserud Ø. Peripheral blood progenitor cell grafts contain high levels of platelet-secreted mediators. Transfusion. 2001;41:1431–7.
   PubMed Web of Science ®Google Scholar
• Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G, . Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater. 2008;84:415–21.
   PubMedGoogle Scholar
• Ryningen A, Stapnes C, Lassalle P, Corbascio M, Gjertsen BT, Bruserud O. A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid. Leuk Res. 2009; 33:779–87.
   PubMed Web of Science ®Google Scholar
• Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, . Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2006;1765:25–37.
   PubMed Web of Science ®Google Scholar
• Edgren G, Reilly M, Hjalgrim H, Tran TN, Rostgaard K, Adami J, . Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst. 2008;100: 572–9.
   PubMed Web of Science ®Google Scholar
• Edgren G, Tran TN, Hjalgrim H, Rostgaard K, Shanwell A, Titlestad K, . Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion. 2007;47:2017–24
   PubMed Web of Science ®Google Scholar